Keyphrases
Multiple Myeloma
100%
Confidence Interval
70%
Monoclonal Gammopathy of Undetermined Significance
65%
Early-stage Lung Cancer
56%
Veterans Health Administration
50%
US Veterans
41%
Overall Survival
36%
Surgical Treatment
36%
Agent Orange
35%
Metformin Use
35%
Type 1 Diabetes Mellitus (T1DM)
35%
Stage I Lung Cancer
34%
Adjusted Odds Ratio
33%
Multivariable
24%
Medical Center
23%
United States Veterans
23%
Treatment Options
21%
Postoperative Outcomes
21%
African American
20%
Population-based Retrospective Cohort Study
19%
Non-small Cell Lung Cancer Patients
19%
Vietnam War
19%
Cancer Recurrence
19%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
18%
Obesity
18%
Natural Language Processing
17%
Splanchnic Vein Thrombosis
17%
Clinical Research
17%
Classification Model
17%
Saint Louis
17%
Advanced Prostate Cancer
17%
Frailty
17%
Comorbid Conditions
17%
Corneal Graft Survival
17%
Outcomes Research
17%
Oncological Outcomes
17%
Older Veterans
17%
Electronic Health Records
17%
Comparative Effectiveness
17%
Keratoconus
17%
Bleomycin
17%
Lymph Node Sampling
17%
Induction Chemoradiation
17%
Cancer Risk
17%
Pneumonitis
17%
Decision Analysis
17%
Pancreatic Ductal Adenocarcinoma
17%
Population-based Study
17%
Monoclonal Protein
17%
Monoclonal Gammopathy
17%
Medicine and Dentistry
Multiple Myeloma
87%
Monoclonal Gammopathy of Undetermined Significance
70%
Lung Cancer
68%
Veterans Health
65%
Non Small Cell Lung Cancer
61%
Odds Ratio
44%
Glycon
35%
Diabetes Mellitus
35%
Pancreas Cancer
35%
Hazard Ratio
31%
Overall Survival
30%
Retrospective Cohort Study
28%
Surgery
26%
Cohort Analysis
24%
Clinical Stage
24%
Patient with Diabetes
21%
Pancreas Adenocarcinoma
20%
Cancer Recurrence
19%
Oncology
19%
Malignant Neoplasm
17%
Graft Survival
17%
Clinical Research
17%
Keratoconus
17%
Neoplasm
17%
Lymph Node
17%
Frailty
17%
Atopy
17%
Corneal Transplantation
17%
Phlebothrombosis
17%
Chemoradiotherapy
17%
Venous Thromboembolism
17%
Hodgkin's Lymphoma
17%
Esophagectomy
17%
Esophageal Cancer
17%
Pulmonary Toxicity
17%
Bleomycin
17%
Glucagon-Like Peptide-1 Agonist
17%
Prescription Medication
17%
Lung Cancer Screening
17%
Comorbidity
15%
Adverse Event
13%
Diseases
11%
Veterans Affairs
10%
Prevalence
10%
Penetrating Keratoplasty
10%
Bleeding
10%
Anticoagulant Therapy
10%
Proportional Hazards Model
8%
Recurrence Free Survival
8%
Computer Assisted Tomography
8%